Empagliflozin Bromo Impurity |
|
|---|---|
| CAT. No : | E510011 |
| Alternate Cat. No : | D780048 |
| CAS. No : | 915095-89-5 |
| Mol. F : | C17H16BrClO2 |
| Mol. Wt : | 367.66 g/mol |
| Synonyms : | Furan,3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-,(3S) |
| Chemical Name : | (S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran |
| Stock Status : | Instock |
- Buy High-Quality Empagliflozin Bromo Impurity from Simson Pharma Limited at best competitive price.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 915095-89-5 | Purchase 915095-89-5 | Order 915095-89-5 | Enquire 915095-89-5 | Price of 915095-89-5 | 915095-89-5 Supplier | 915095-89-5 Manufacturer | 915095-89-5 Exporter | Empagliflozin Bromo Impurity for Method Validation | Empagliflozin Bromo Impurity Reference Standard | Empagliflozin Bromo Impurity for ANDA Filing | Empagliflozin Bromo Impurity for Forced Degradation Studies | Empagliflozin Bromo Impurity Identification Standards | Empagliflozin Bromo Impurity for DMF Filing | Buy high quality Empagliflozin Bromo Impurity | Purchase Empagliflozin Bromo Impurity | Empagliflozin Bromo Impurity suppliers | Empagliflozin Bromo Impurity manufacturers | Empagliflozin Bromo Impurity price | Empagliflozin Bromo Impurity exporter | Order Empagliflozin Bromo Impurity | Enquire Empagliflozin Bromo Impurity | Empagliflozin Bromo Impurity cost | Empagliflozin Bromo Impurity Supplier | Empagliflozin Bromo Impurity Distributor
Related Products
Discover all
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
